Colossal Biosciences is a biotechnology and genetic engineering company that uses gene editing technology to de-extinct species.
Colossal Biosciences has raised $60.0M in total funding. The most recent round was Series C. The last funding was announced in February 2026.
Colossal Biosciences is headquartered in Austin, United States.
Colossal Biosciences is a biotechnology and genetic engineering company that uses gene editing technology to de-extinct species.
Colossal Biosciences is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Colossal Biosciences — Funding & Investors." VCBacked, February 3, 2026, https://www.vcbacked.co/company/colossal-biosciences. Accessed September 2, 2026.
VCBacked. (2026). Colossal Biosciences — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/colossal-biosciences
{{cite web |title=Colossal Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/colossal-biosciences |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated